|
Novosense AB will be the
first in the market to offer a completely wireless system for the recording and
transmission of ECG signals.
Novosense has
considerable expertise in product development for the medical market as well as market
experience and company management within this area.
The company has filed
a patent application covering new methods of wireless registration of ECG
signals, as well as a new structure for the wireless transmission
of these signals.
The company has signed a
technology license agreement with Acreo AB covering existing and future
technologies within several important areas, e.g. low-cost production
technology, radio and sensor technology.
A clinical study has been performed to
validate the technology. The study provide a clear
Proof of Concept. Novosense is now
developing the commercial product.
To receive further information, please e-mail
Jonas Tilly.
|
